American International Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-20,337
| Closed | -$37.6K | – | 3257 |
|
2023
Q1 | $37.6K | Buy |
20,337
+405
| +2% | +$749 | ﹤0.01% | 2785 |
|
2022
Q4 | $22.1K | Sell |
19,932
-72
| -0.4% | -$80 | ﹤0.01% | 2913 |
|
2022
Q3 | $47K | Buy |
20,004
+282
| +1% | +$663 | ﹤0.01% | 2831 |
|
2022
Q2 | $60K | Buy |
19,722
+3,355
| +20% | +$10.2K | ﹤0.01% | 2820 |
|
2022
Q1 | $111K | Sell |
16,367
-1,152
| -7% | -$7.81K | ﹤0.01% | 2555 |
|
2021
Q4 | $146K | Sell |
17,519
-524
| -3% | -$4.37K | ﹤0.01% | 2547 |
|
2021
Q3 | $134K | Sell |
18,043
-429
| -2% | -$3.19K | ﹤0.01% | 2660 |
|
2021
Q2 | $126 | Buy |
18,472
+8,415
| +84% | +$57 | ﹤0.01% | 2783 |
|
2021
Q1 | $103 | Buy |
10,057
+27
| +0.3% | – | ﹤0.01% | 2707 |
|
2020
Q4 | $70 | Sell |
10,030
-288
| -3% | -$2 | ﹤0.01% | 2838 |
|
2020
Q3 | $84K | Sell |
10,318
-235
| -2% | -$1.91K | ﹤0.01% | 2623 |
|
2020
Q2 | $73K | Buy |
10,553
+975
| +10% | +$6.75K | ﹤0.01% | 2717 |
|
2020
Q1 | $45K | Sell |
9,578
-554
| -5% | -$2.6K | ﹤0.01% | 2728 |
|
2019
Q4 | $88K | Sell |
10,132
-84
| -0.8% | -$730 | ﹤0.01% | 2700 |
|
2019
Q3 | $34K | Sell |
10,216
-72
| -0.7% | -$240 | ﹤0.01% | 2969 |
|
2019
Q2 | $51K | Buy |
10,288
+234
| +2% | +$1.16K | ﹤0.01% | 2939 |
|
2019
Q1 | $62K | Sell |
10,054
-326
| -3% | -$2.01K | ﹤0.01% | 2807 |
|
2018
Q4 | $35K | Sell |
10,380
-80
| -0.8% | -$270 | ﹤0.01% | 2958 |
|
2018
Q3 | $68K | Buy |
10,460
+189
| +2% | +$1.23K | ﹤0.01% | 2987 |
|
2018
Q2 | $79K | Buy |
10,271
+1,018
| +11% | +$7.83K | ﹤0.01% | 2883 |
|
2018
Q1 | $207K | Sell |
9,253
-499
| -5% | -$11.2K | ﹤0.01% | 2246 |
|
2017
Q4 | $124K | Buy |
9,752
+193
| +2% | +$2.45K | ﹤0.01% | 2615 |
|
2017
Q3 | $149K | Buy |
9,559
+5,442
| +132% | +$84.8K | ﹤0.01% | 2450 |
|
2017
Q2 | $58K | Buy |
+4,117
| New | +$58K | ﹤0.01% | 2966 |
|